Role of CD38 in TNF-α-induced airway hyperresponsiveness
- 1 February 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 294 (2), L290-L299
- https://doi.org/10.1152/ajplung.00367.2007
Abstract
CD38 is involved in normal airway function, IL-13-induced airway hyperresponsiveness (AHR), and is also regulated by tumor necrosis factor (TNF)-α in airway smooth muscle (ASM) cells. This study aimed to determine whether TNF-α-induced CD38 upregulation in ASM cells contributes to AHR, a hallmark of asthma. We hypothesized that AHR would be attenuated in TNF-α-exposed CD38-deficient (CD38KO) mice compared with wild-type (WT) controls. Mice (n = 6–8/group) were intranasally challenged with vehicle control or TNF-α (50 ng) once and every other day during 1 or 4 wk. Lung inflammation and AHR, measured by changes in lung resistance after inhaled methacholine, were assessed 24 h following the last challenge. Tracheal rings were incubated with TNF-α (50 ng/ml) to assess contractile changes in the ASM. While a single TNF-α challenge caused no airway inflammation, both multiple-challenge protocols induced equally significant inflammation in CD38KO and WT mice. A single intranasal TNF-α challenge induced AHR in the WT but not in the CD38KO mice, whereas both mice developed AHR after 1 wk of challenges. The AHR was suppressed by extending the challenges for 4 wk in both mice, although to a larger magnitude in the WT than in the CD38KO mice. TNF-α increased ASM contractile properties in tracheal rings from WT but not from CD38KO mice. In conclusion, CD38 contributes to TNF-α-induced AHR after a brief airway exposure to the cytokine, likely by mediating changes in ASM contractile responses, and is associated with greater AHR remission following chronic airway exposure to TNF-α. The mechanisms involved in this remission remain to be determined.Keywords
This publication has 60 references indexed in Scilit:
- CD38-deficient mice have reduced airway hyperresponsiveness following IL-13 challengeAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Transcriptional regulation of CD38 expression by tumor necrosis factor‐α in human airway smooth muscle cells: role of NF‐κB and sensitivity to glucocorticoidsThe FASEB Journal, 2006
- Chronic exposure to TNF-α increases airway mucus gene expression in vivoJournal of Allergy and Clinical Immunology, 2005
- CD38 Expression Is Insensitive to Steroid Action in Cells Treated with Tumor Necrosis Factor-α and Interferon-γ by a Mechanism Involving the Up-Regulation of the Glucocorticoid Receptor β IsoformPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2005
- Adenoviral mediated anti-sense CD38 attenuates TNF-α-induced changes in calcium homeostasis of human airway smooth muscle cellsCanadian Journal of Physiology and Pharmacology, 2005
- Airway smooth muscle excitation-contraction coupling and airway hyperresponsivenessCanadian Journal of Physiology and Pharmacology, 2005
- CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscleAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Tumor Necrosis Factor-α Differentially Regulates the Expression of Proinflammatory Genes in Human Airway Smooth Muscle Cells by Activation of Interferon-β–Dependent CD38 PathwayPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Tumor Necrosis Factor-α–Induced Activation of RhoA in Airway Smooth Muscle Cells: Role in the Ca2+Sensitization of Myosin Light Chain20PhosphorylationMolecular Pharmacology, 2003
- Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthmaImmunology & Cell Biology, 2001